Further investigation of similar tumor subtypes in the urothelial tract should include genome-wide analyses, specifically focusing on KRAS mutation status and microsatellite instability testing, to better understand the molecular basis for the proposed intestinal metaplasia-dysplasia-carcinoma sequence in this rare primary urothelial neoplasm. This evidence concerns the gene KRAS and neoplasm.